Posts Tagged ‘allegra’

Troublesome Allergens Thrive In Humid Weather

Tuesday, July 8th, 2008

About 40 million Americans suffer from "hay fever," a disease that allergists prefer to call "allergic rhinitis," because HAY is not to blame and FEVER is rarely a symptom.
So what is causing the stuffy runny nose, the watery itchy eyes, the sneezing, wheezing and cough, and why are heavy rains and melting snow making symptoms worse?
"There are dozens of substances that potentially can cause trouble in those of us who are susceptible to allergies, but trees are usually the first on the scene during spring allergy season," said Jay M. Portnoy, M.D., president of the American College of Allergy, Asthma and Immunology (ACAAI) and chief, section of allergy, asthma & immunology at Children’s Mercy Hospitals & Clinics in Kansas City, Mo. "Rain can provide some initial relief by reducing tree pollen counts, but it also can spur the growth of grass and weeds later in the spring and in early summer, producing more pollen."
Paul Ratner, M.D., Medical Director of Sylvana Research in San Antonio, Texas, said "A dry and cold winter followed by recent heavy rains has resulted in a slightly delayed onset of spring tree pollens. The primary tree pollen, Oak, began appearing mid-March, and within a week, extremely high pollen counts were recorded. The tree pollen season is expected to last through early May."
Heavy precipitation in many areas of the U.S. is associated with a greater release of seasonal pollens according to Clifford W. Bassett, M.D., a fellow of the ACAAI and a clinical assistant professor of medicine at the Long Island College Hospital in Brooklyn, N.Y.
"We are seeing many patients over the past several weeks, both adults and children, with complaints that may be difficult for them to differentiate from a cold, allergy or sinus problem. Once they are diagnosed with a seasonal allergy, an individual allergy treatment program can be prescribed for their relief," Dr. Bassett said.
"Last year we had record high pollen levels in New York City and expect that trend to continue. It’s very important to begin treatment before symptoms progress," he said.
There has been a prolonged snow cover on the ground from mid-November through mid-March said ACAAI President-Elect Richard G. Gower, M.D., Marycliff Allergy Specialists in Spokane, Wash. "Melting snow has revealed an abundance of outdoor mold growth and the use of indoor humidifiers has contributed to increased indoor mold counts. Trees began pollinating in early February and will continue through June, overlapping with our grass season in May and June."
The five most common allergens, according to the ACAAI are:
1. Trees produce pollen, the dust-like, male reproductive parts of plants that cause most allergies. In some southern states, trees can produce pollen as early as January, while pollen production usually begins in April in the north. The oak tree, which is prevalent throughout the United States, produces large quantities of pollen and is a major cause of allergies. Evergreens also can be troublemakers. Cedar, juniper, cypress and sequoia trees have all been known to cause allergies and if you’re allergic to one, you may be allergic to them all. Other suspects include elm trees, which are common in the eastern and midwestern regions, birch trees, olive trees, sycamores, and poplars, including cottonwoods, balsam and aspen.
2. Grasses usually come along to stir up allergy symptoms after trees are through pollinating typically from late spring to early summer. Common culprits are timothy grass, Bermuda grass, sweet vernal, red top and some blue grasses.
3. Weeds are guilty of causing most of the allergy misery that occurs in the late summer and early fall. Buy lexapro without prescription Top on the list of offenders is ragweed which affects as many as 75 percent of all hay fever sufferers. Ragweed is found in virtually every region of the United States and, with 17 different species of the weed, there’s plenty of pollen to keep people sneezing and sniffling until frost. Other common weed allergens are sagebrush, found predominantly in the west, pigweed and goosefoot pollen.
4. Molds are microscopic plants that reproduce by sending tiny spores into the air. They thrive in areas that are warm, dark and moist. Unlike pollen, which appears only in the warm weather months, mold can lurk in your house year-round.
5. Dust Mites are small (hundreds can live in a single gram of dust), eight-legged creatures that belong to the same family as spiders, chiggers and ticks. These culprits are hardy creatures that live well and multiply easily in warm, humid places. Favorite hideouts include carpets, upholstered furniture, bedding, clothes, soft toys and the fur of pets. The intruder is particularly malicious when trapped inside a closed-up house.
An allergist-immunologist is a physician who specializes in the diagnosis and treatment of asthma and other allergic diseases. The allergist is specially trained to identify the allergic and non-allergic factors that trigger asthma and other allergic diseases. Allergists help people treat or prevent their allergy problems. After earning a medical degree, the allergist-immunologist completes a three-year residency training program in either internal medicine or pediatrics. Next the allergist completes two or three more years of study in the field of allergy-immunology in order to prepare for certification by the American Board of Allergy and Immunology.
The American College of Allergy, Asthma and Immunology (ACAAI) is a professional medical organization headquartered in Arlington Heights, Ill., that promotes excellence in the practice of the subspecialty of allergy and immunology. The College, comprising more than 5,000 allergists-immunologists and related health care professionals, fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy and research.
American College of Allergy, Asthma and Immunology (ACAAI)
85 W. Algonquin Rd., Ste 550
Arlington Heights, IL 60005
United States

Generic clomid pills no prescription | generic viagra online buy | Generic lexapro pills no prescription

Auriga Laboratories Announces The Launch Of Extendryl(R) PEM And Extendryl(R) GCP

Monday, July 7th, 2008

Auriga Laboratories, Inc. (OTCBB: ARGA), a specialty pharmaceutical company, announced today the launch of Extendryl® PEM and Extendryl® GCP. The two new products will be marketed under the Extendryl brand name which consists of prescription products to treat various cough, cold, and allergy symptoms.
The prescription respiratory market is valued at more than 8 billion dollars in sales and more than 68 million prescriptions are written annually in the US. Extendryl® PEM (phenylephrine HCl 30 mg; methscopolamine nitrate 1.25 mg) Tablets combine two compounds; a decongestant with an anticholinergic/drying agent in an extended release format to provide 8 to 12 hours of relief of symptoms for adults suffering from nasal congestion and mucosal drainage associated with respiratory tract infections and related conditions such as sinusitis, pharyngitis, bronchitis, and asthma. Extendryl® GCP Oral Solution combines three compounds (100 mg/5 mL guaifenesin; 15 mg/5mL carbetapentane citrate; 5 mg/mL hydrochloride), and is indicated for temporary relief of non-productive cough accompanying respiratory tract congestion associated with the common cold, influenza, sinusitis, and bronchitis.
Extendryl® PEM and Extendryl®GCP will be launched in March 2008. "These new products further solidify Auriga’s commitment to enhance the Extendryl product line, and the launch is well timed to coincide with the start of Spring allergy season. These new additions to the Extendryl family will be a highly synergistic addition to Auriga’s current promotional efforts," said Frank Greico, Chief Executive Officer of Auriga.
Extendryl is contraindicated in patients who are sensitive to any of the ingredients or related compounds, and in patients with glaucoma, hypertension, cardiac disease, hyperthyroidism, urinary retention, peptic ulcer, patients on MAO inhibitor therapy and during an asthmatic attack. Extendryl GCP is contraindicated in women who are pregnant and/or nursing. Extendryl PEM is contraindicated in children under 6 years of age. Buy generic amoxil See individual product package inserts for full prescribing information.
About Auriga Laboratories™
Auriga Laboratories is a specialty pharmaceutical company building an extensive product portfolio of prescription brands targeting high growth therapeutic categories in the respiratory, dermatology, and psychiatry markets, which have combined annual revenues of more than fifteen billion dollars in the United States. The company’s high-growth business model combines driving revenues through a primarily variable cost commission-based sales structure, acquisition of proven brand names, introduction of new brands, and a strategic development pipeline, all of which designed to enhance its growing direct relationships with physicians nationwide. Auriga’s exclusive prescription and over-the-counter product portfolio includes Aquoral™ for the treatment of Xerostomia, Akurza™, Xyralid™, Zytopic™, and Coraz™ dermatology products, and the Zinx™ Extendryl ®, and Levall ® Families of products for relief of symptoms associated with a range of acute respiratory diseases. For more information, visit
Forward-Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to the company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause its actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to its operations, results of operations, growth strategy and liquidity.
The company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company’s expectations include, but are not limited to, those factors that are disclosed under the heading "Risk Factors" and elsewhere in documents filed by the company from time to time with the United States Securities and Exchange Commission and other regulatory authorities. Statements regarding the company’s ability to increase its sales force and the success of such sales force in selling its products in light of competitive and other factors, the regulatory status and/or regulatory compliance of its products, the development of additional products, its ability to sustain market acceptance for its products, its dependence on collaborators, the company’s exposure to product liability claims, and the company’s prices, future revenues and income and cash flows and other statements that are not historical facts contain predictions, estimates and other forward-looking statements. Although the company believes that its expectations are based on reasonable assumptions, it can give no assurance that its goals will be achieved and these statements will prove to be accurate. Important factors could cause actual results to differ materially from those included in the forward-looking statements.
Auriga Laboratories
generic acomplia online buy | Generic clomid pills no prescription | Buy levitra without prescription

Maximum Life’s Product Navitol Clinically Proven To Reduce Systolic Blood Pressure

Sunday, July 6th, 2008

For Health Professionals
Latest News For Hypertension
CocoaVia Dark Chocolate Bars Shown To Lower Cholesterol
22 Apr 2008
Electronic Handheld Blood Pressure Devices Market To Reach 793 Million Dollars By 2010, According To New Report By Global Industry Analysts, Inc.
22 Apr 2008
New Antihypertensive PritorPlus® 80/25 And Kinzalkomb® 80/25 Approved By EU Commission
21 Apr 2008
View more news…
Latest Videos for Hypertension
Medications and Diet for hypertension
Hypertension or high blood pressure is a risk factor for heart disease, stroke and other cardiovascular conditions. Fortunately, it can be controlled. Tune in to find out how…
Diabetes and Hypertension
Controlling blood sugar levels are crucial for people with diabetes. But equally important is blood pressure control. generic propecia online buy High blood pressure and diabetes often occur together and if left untreated can lead to serious consequences. Join experts as they discuss the link between these two conditions, who…
View more videos…
Advertisements
Add Your Advertisement Here
Most Popular Categories
public health
neurology
nutrition
cancer
cardiovascular
hiv
diabetes
dermatology
obesity
alcohol
psychology

women’s health
infectious diseases
pediatrics
breast cancer
urology
pregnancy
gastrointestinal

pain
respiratory
prostate
bones
depression
smoking
medical devices
health insurance
medicare
hypertension
stem cell research
biology
alzheimer’s
sexual health
sleep
abortion
genetics
allergy
autism
eye health
adhd
it
multiple sclerosis
sports medicine
pharma industry
dentistry
liver disease
anxiety
arthritis
seniors

cholesterol
mrsa
Buy cialis without prescription | Buy propecia pills | Buy levitra without prescription